Linac-based stereotactic radiosurgery and radiotherapy;Radiothérapie stéréotaxique par accélé rateurs adaptés ou dédiés

Bulletin du Cancer

Volumn 97, Issue 7, 2010, Pages 791-806

  Ayadi, M ^a   Ginestet, C ^a   Gassa, F ^a   Claude, L ^a   Mazeron, J J ^b  

^a UNIVERSITÉ DE LYON   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Adapted or dedicated linear accelerators; Multiple static beams; Precise targeting; Small tumors; Stereotactic radiotherapy

Indexed keywords

ACCURACY; ALGORITHM; CANCER CONTROL; CANCER RADIOTHERAPY; COLLIMATOR; DEVICE; DOSIMETRY; HUMAN; IMMOBILIZATION; LINEAR ACCELERATOR; LIVER TUMOR; LUNG TUMOR; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIODENSITOMETRY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TECHNIQUE; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION; TUMOR LOCALIZATION;

EID: 77955600922     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1144     Document Type: Review

References (67)

1. Betti OO. Historique de la radiochirurgie. Cancer Radiother 1998; 2: 101-4.
2. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951; 102: 316-9.
3. Castel JP. Radiochirurgie des malformations artérioveineuses cérébrales. Stratégie thérapeutique. Cancer Radiother 1998; 2: 180-90.
4. Flickinger JC, Kondzioka D, Pollock BE, Maitz AH, Lunsford L. Complications from arterioveinous malformations radiosurgery: multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys 1997; 38: 485-90. (Pubitemid 27305007)
5. Régis J, Pelis W. Radiochirurgie ou microchirrugie des schwannomes vestibulaires. Cancer Radiother 1998; 2: 191-201.
6. Simon JM, Noël G, Boisserie G, Cornu P, Mazeron JJ. Cancer Radiother 2002; 6: 144s-154s.
7. Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006; 59: 77-85.
8. Flickinger JC, Kondziolka D, Niranjan A, Maitz A, Voynov G, Lunsford LD. Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 2004; 60: 225-30.
9. Murraciole X, Régis J, Péragut JC, Juin P. Radiochirurgie des métastases cérébrales. Cancer Radiother 1998; 2: 202-6.
10. Noël G, Feuvret L, Boisserie G, Mazeron JJ. La radiothérapie en conditions stéréotaxiques des métastases cérébrales: réflexions, controverses et questions sans réponse en 2004. Bull Cancer 2004; 91: 81-93.
11. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1265-72.
12. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45: 427-34. (Pubitemid 29408559)
13. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295: 2483-91.
14. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009; 1: 1037-44.
15. Kocher M, Mueller RP, Abacioglu MU, Villa S, Fauchon F, Baumert BJ, et al. Adjuvant whole brain radiotherapy vs observation after radiosurgery or surgical resection of 1-3 cerebral metastases - Results of the EORTC 22952-6001 study. Int J Radiat Oncol Biol Phys 2009; 75 (suppl: 5s).
16. Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009; 185: 235-40.
17. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Shomber G, et al. Meningioma radiosurgery; tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001; 49: 1029-37.
18. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003; 41: 1-11. (Pubitemid 36765477)
19. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010-5. (Pubitemid 41505277)
20. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009; 75: 677-82.
21. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. IntJRadiatOncol Biol Phys 2005; 63: 1427-31.
22. Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27: 3290-6.
23. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-9.
24. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006; 16: 77-84.
25. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186-96.
26. Lee SW, Choi EK, Park HJ, Ahn SD, Kim JH, Kim KJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003; 40: 309-15.
27. Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol 2006; 182: 696-702. (Pubitemid 44887170)
28. Thariat J, Li G, Angellier G, Marchal S, Palamini G, Rucka G, et al. Current indications and ongoing clinical trials with Cyberknife® stereotactic radiotherapy in France in 2009. Bull Cancer 2009; 96: 853-64.
29. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007; 32: 193-9.
30. Abrams RA, Pajak TF, Haulk TL, Flam M, Asbell SO. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins oncology center. Cancer J Sci Am 1998; 4: 178-84.
31. Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210-8.
32. Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 2006; 36: 154-8.
33. Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006; 45: 838-47. (Pubitemid 44423130)
34. Mendez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 2006; 45: 831-7.
35. Gunven P, Blomgren H, Lax I, Levitt SH. Curative stereotactic body radiotherapy for liver malignancy. Med Oncol 2009; 26: 327-34.
36. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007; 67: 793-8. (Pubitemid 46215888)
37. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009; 27: 1585-91.
38. Stereotactic Radiosurgery. College Park, Md: American Association of Physicists in Medicine; AAPM Report 54; Task group 42; 1995.
39. Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, et al. American society for therapeutic radiology and oncology and american college of radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60: 1026-32.
40. ICRU. Prescribing, recording and reporting photon beam therapy. Report 50, 1993. Bethesda. USA.
41. ICRU. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Report 62, 1999. Bethesda. USA.
42. Ryu S, Fang Yin F, Rock J, Zhu J, Chu A, Kagan E, et al. Image guided and intensity-modulated radiosurgery for patient with spinal metastasis. Cancer 2003; 97: 2013-8. (Pubitemid 36397280)
43. Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, et al. Image-guided hypofractionated stereotactic radiosurgery to spinal lesions. Neurosurgery 2001; 49: 838-46.
44. Wachter T, Bouscayrol H, Champeaux E, Verrelle P, Giraud P. Extracranial stereotaxic body irradiation: preliminary results and the Orleans hospital experience. Bull Cancer 2008; 95: 153-60.
45. Gassa F, Biston MC, Malet C, Lafay F, Ayadi M, Badel JN, et al. The stereotactic body radiation therapy: initiation and clinical program. Cancer Radiother 2006; 10: 444-50.
46. Lax I, Blomgren H, Nüslund I, Svanström R, et al. Stereotactic radiotherapy of malignancies in abdomen: methodological aspects. Acta Onco 1994; 33: 677-83. (Pubitemid 24345376)
47. Lax I, Blomgren H, Larson D, et al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg 1998; 1: 135-48.
48. Aoyama H, Kamada K, Shirato H, Takeuchi F, Kuriki S, Iwasaki Y, et al. Integration of functional brain information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat Oncol Biol Phys 2004; 58: 1177-83.
49. Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 2007; 56: 229-34 (Epub 2007 Mar 13). (Pubitemid 46590486)
50. Geets X, Lee JA, Castadot P, Bol A, Grégoire V. Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers. Cancer Radiother 2009; 13: 594-9.
51. Wolthaus J, Sonke JJ, van Herk M, et al. Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. Int J Radiat Oncol Biol Phys 2008; 70: 1229-38.
52. Rietzel E, Pan T, Chen GT. Four-dimensional computed tomography: image formation and clinical protocol. Med Phys 2005; 32: 874-89. (Pubitemid 40586772)
53. van Sörnsen de Koste J, Lagerwaard FJ, Nijssen-Visser MR, Graveland WJ, Senan S. Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans. Int J Radiat Oncol Biol Phys 2003; 56: 348-54. (Pubitemid 36542892)
54. Wunderink W, Romero AM, de Kruif W, et al. Reduction of respiratory liver tumor motion by abdominal compression in stereotactic body frame, analyzed by tracking fiducial markers implanted in liver. Int J Radiat Oncol Biol Phys 2008; 71: 907-15.
55. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004; 14: 52-64.
56. Timmerman R, Michalski J, Galvin J, Fowler JF, Choy H, Gore E, et al. RTOG 0236: a phase II trial stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stageI/II non-small cell lung cancer. RTOG, 2006.
57. Manens JP, Buchheit I, Beauvais H, Gaboriaud G, Mazal A, Piret P. Dosimetry of small-size photon beams. Cancer Radiother 1998; 2: 105-14.
58. Verbakel WF, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 2009; 93: 122-4.
59. Knöös T, Ahnesjö A, Nilsson P, et al. Limitation of a pencil beam approach tophoton dose calculation in lung tissue. Phys Med biol 1995; 40: 1411-20.
60. Haedinger U, Krieger T, Flentje M, Wulf J. Influence of the calculation model on dose distribution in stereotactic radiosurgery of pulmonary targets. Int J Radiat Oncol Biol Phys 2005; 61: 239-49.
61. Ahnesjö A. Collapsed cone convolution of radiant energy of photon dose calculationin heterogeneous med. Med Phys 1989; 16: 577-92.
62. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. Clin Oncol (R Coll Radiol) 2008; 20: 666-76.
63. Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008; 3: 36.
64. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27: 1572-8.
65. Prezado Y, Fois G, Edouard M, Nemoz C, Renier M, Requardt H, et al. Biological equivalent dose studies for dose escalation in the stereotactic synchrotron radiation therapy clinical trials. Med Phys 2009; 36: 725-33.
66. Niemierko. A Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 1997; 24: 103-10.
67. Pommier P, Gassa F, Lafay F, Claude L. Image guided radiotherapy with the cone beam CT kV (Elekta): experience of the Léon-Bérard centre. Cancer Radiother 2009; 13: 384-90.